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Toward Diagnosing Leishmania infantum Infection in
Asymptomatic Dogs in an Area Where Leishmaniasis Is
Endemic
Abstract
The most frequently used diagnostic methods were compared in a longitudinal survey with Leishmania
infantum-infected asymptomatic dogs from an area of Italy where leishmaniasis is endemic. In February
and March 2005, 845 asymptomatic dogs were tested by an immunofluorescence antibody test (IFAT), a
dipstick assay (DS), and an enzyme-linked immunosorbent assay (ELISA) for L. infantum and by IFAT
for Ehrlichia canis. Dogs seronegative for L. infantum were further parasitologically evaluated by
microscopic examination of lymph node tissues and PCR of skin samples. A total of 204 animals both
serologically and parasitologically negative for L. infantum at the first sampling were enrolled in the
trial and were further examined for canine leishmaniasis (CanL) and canine monocytic ehrlichiosis in
November 2005 (i.e., the end of the first sandfly season) and March 2006 and 2007 (1- and 2-year
follow-ups, respectively). At the initial screening, the overall rates of L. infantum seroprevalence were
9.5% by IFAT, 17.1% by ELISA, and 9.8% by DS and the overall rate of E. canis seroprevalence was
15%. The rates of concordance between the results of IFAT and DS were almost equal, whereas the rate
of concordance between the results of IFAT and DS and those of the ELISA was lower. The results of
the annual incidence of Leishmania infection were variable, depending on the test employed, with the
highest values registered for PCR (i.e., 5.7% and 11.4% at the 1- and 2-year follow-ups, respectively),
followed by ELISA, IFAT, and DS. Over the 2 years of observation, 55 animals (i.e., 26.9%) became
positive for L. infantum by one or more diagnostic tests at different follow-up times, with 12.7%
showing clinical signs related to CanL, while the remaining 87.3% were asymptomatic. A diagnostic
scheme for assessment of the L. infantum infection status in asymptomatic dogs is suggested.
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 2 
ABSTRACT 22 
The most frequently used diagnostic methods were compared in a longitudinal survey on 23 
Leishmania infantum infected asymptomatic dogs from an endemic area of Italy. On February 24 
-March 2005, 845 asymptomatic dogs were tested by IFAT, dipstick -DS- and ELISA tests for 25 
L. infantum and by IFAT for Ehrlichia canis. Dogs seronegative to L. infantum were further 26 
parassitologically evaluated by microscopical examination of lymph node and PCR on skin 27 
sample. 204 animals both serologically and parasitologically negative to L. infantum at the 28 
first sampling were enrolled in the trial and further examined for canine leishmaniasis (CanL) 29 
and for canine monocytic ehrlichiosis (CME) in November 2005 (i.e. the end of the first 30 
sandfly season), in March 2006 and 2007 (one and two year follow-ups respectively). At the 31 
initial screening the overall seroprevalence rates for L. infantum were 9.5% by IFAT, 17.1% 32 
by ELISA, 9.8% by DS and for E. canis 15%. Concordance between IFAT and DS was 33 
almost equal, whereas concordance with ELISA was lower. The results of the annual 34 
incidence of Leishmania infection were variable depending by the test employed with the 35 
highest values registered at the PCR (i.e. 5.7% and 11.5%) followed by the ELISA, IFAT and 36 
DS. Throughout the two years of observation, 55 animals (i.e. 26.9%) became positive for L. 37 
infantum at one or more diagnostical test at different follow-ups with 12.7% showing clinical 38 
signs related to CanL infection while the remaining 87.3% being asymptomatic. A 39 
diagnostical scheme to asses the infected status of L. infantum in asymptomatic dogs is here 40 
suggested. 41 
 42 
 43 
Key words: Leishmania infantum, leishmaniasis, asymptomatic dogs, endemic area, 44 
diagnosis, PCR, IFAT, ELISA, dipstick.  45 
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 3 
1. INTRODUCTION 47 
Canine leishmaniasis (CanL) due to Leishmania infantum is transmitted by different species 48 
of Phlebotomus and it is considered one of the most important canine protozoal diseases of 49 
zoonotic concern (2). L. infantum is widely distributed in many Mediterranean countries and 50 
in Italy stable endemic foci have been reported in dogs from central and southern areas (4, 5, 51 
30, 32) with high percentages (up to 53.1%) of serologically positive animals (5). More 52 
recently, infections by L. infantum have spread through northern Italian regions (19). In 53 
central Europe CanL is a well known and emerging travel associated disease and occasional 54 
focal autochthonous transmission of Leishmania has been suspected (16). In dogs, infections 55 
may cause severe clinical forms or may remain asymptomatic for a long time (5, 7, 17). Many 56 
clinical features of CanL (e.g. lethargy, weight loss, anorexia, epistaxys, lymphadeno- spleno-57 
megaly) may be similar to those of other diseases including Canine Monocytic Ehrlichiosis 58 
(CME) (13). Indeed, along with CanL, CME by Ehrlichia canis is an important canine vector 59 
borne disease (CVBD) in several countries of the Mediterranean basin (40) transmitted by the 60 
brown dog tick Rhipicephalus sanguineus. In endemic areas, CanL may represent a veterinary 61 
and public health issue mainly due to the high percentage of asymptomatic animals (up to 62 
85%) in endemic areas (7) which may serve, similarly to symptomatic ones, as reservoirs for 63 
the vector borne transmission of Leishmania spp. to receptive animals and humans (22, 24). 64 
Thus, the reliable identification of Leishmania infected asymptomatic reservoir animals is 65 
crucial for any successful control strategy. 66 
The definitive diagnosis of Leishmania infection in asymptomatic animals is troublesome 67 
since both serological and parasitological methods have inherent limitations (23). Indeed, 68 
serology may not be a good indicator of infection when used in cross sectional studies due to 69 
the varying time spanning between infection and seroconversion (i.e. from 3 months to 7 70 
years-[1]). Additionally, asymptomatic infected animals may remain seronegative as a 71 
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 4 
consequence of their individual immune response (3). Among the direct parasitological tests 72 
microscopical examination is a rapid and simple method, but has a low sensitivity, 73 
particularly in asymptomatic dogs, and thus is not recommended for mass screenings in 74 
endemic areas. In vitro culture techniques, although reliable and sensitive, are prone to 75 
microbiological contamination (12), especially if skin samples or samples collected under 76 
field conditions are used. Molecular tools have been developed to detect Leishmania DNA in 77 
putative dog reservoirs (33) and have been shown to be more sensitive than serology and 78 
culture techniques (10). Thus, although polymerase chain reactions (PCR) can be useful in 79 
detecting asymptomatic infected animals (10, 27) defining methodologies, protocol of 80 
amplifications, gene targets and tissue to be tested is matter of debate among scientists (6, 35).  81 
As a consequence, data currently available in literature about diagnosis of CanL in 82 
asymptomatic animals are controversial and a diagnostic “gold standard” is far from being 83 
clearly stated (23). Again, no longitudinal studies are available to investigate the serological 84 
and parasitological features in the course of first L. infantum infection in asymptomatic 85 
animals from an endemic area for CVBDs. Thus, it was the aim of the present study to 86 
compare the most frequently used diagnostic methods in a longitudinal survey on L. infantum 87 
infected asymptomatic dogs from endemic areas.  88 
 89 
2. MATERIAL AND METHODS 90 
2.1. Study design 91 
From January 2005 to March 2007 samples were collected from dogs in the context of a 92 
previous field trial (29) with further sampling in March 2007 (see below). All animals were 93 
housed in two kennels of the Apulian region, southern Italy (latitude 42° and 39° North, 94 
longitude 15° and 18° East) where endemic CanL had been reported over the previous two 95 
years (30). Animals were kept (i.e. housing, food, temperature regulation and ventilation) 96 
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 5 
under their usual housing conditions (29). Animals were handled and sampled with the 97 
owners’ consent and approval by the Ethical Committee of the Faculty of Veterinary 98 
Medicine of the University of Bari (Italy). Sex, age, weight and coat length were recorded for 99 
each dog.  100 
Briefly, in January and February 2005 (i.e. in the absence of sandflies in the study area [18]) 101 
about 2000 dogs were clinically evaluated. 845 dogs of both sexes and different ages that did 102 
not show any signs of dermatitis or lymphadeno-megaly were further tested by an 103 
immunofluorescence antibody test (IFAT), an immunochromatographic dipstick assay (DS) 104 
and an enzyme linked immunosorbent assay (ELISA) for the presence of specific anti-105 
Leishmania antibodies and by IFAT for specific anti -E. canis antibodies. Dogs without 106 
detectable anti-Leishmania antibodies were further examined for the presence of amastigote 107 
stages of Leishmania parasites in stained lymph node smears and for Leishmania-DNA in 108 
dermal tissue samples by PCR (see below).  109 
In March 2005, 204 animals (i.e. 102 for each kennel) which were both serologically and 110 
parasitologically negative for L. infantum were enrolled in a longitudinal follow up trial, 111 
irrespective of the presence of anti-E. canis antibodies. All animals remained untreated with 112 
any ecto-parasiticide through the study. They were examined serologically and 113 
parasitologically for CanL and CME in November 2005 (i.e. the end of the first sandfly 114 
season), in March 2006 (one year follow-up) and in March 2007 (two years follow-up). 115 
Specifically, serological tests for the presence of anti-Leishmania antibodies (IFAT, ELISA, 116 
DS) and anti-E. canis antibodies (IFAT) as well as PCR for the detection of Leishmania DNA 117 
in dermal tissue samples were performed at all follow up times. Additionally, lymph node 118 
smears were examined microscopically in March 2006 and 2007 for the presence of 119 
amastigote Leishmania stages. Clinical examinations were performed monthly and clinical 120 
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 6 
signs (i.e. lethargy, weight loss, anorexia, alopecia, dermatitis, conjunctivitis, epistaxys, 121 
onychogryphosis, lymphadenomegaly, etc.) were recorded.  122 
2.2. Diagnostic procedures  123 
2.2.1. Serological tests 124 
Three different serological tests were used to reveal specific anti-Leishmania IgG antibodies. 125 
IFAT. The test was performed using promastigotes of L. infantum zymodeme MON1 as 126 
antigen. The cells were exposed to sera diluted (1:80) in phosphate buffered saline (PBS) in a 127 
moist chamber, and then to fluorescinated rabbit anti-dog IgG serum diluted 1:40 (Rabbit 128 
anti-dog IgG; Sigma - Aldrich Chemie, Germany, Lot 125K4752) both at 37°C for 30 min. 129 
Samples were scored positive when they produced a clear cytoplasmatic or membrane 130 
fluorescence with promastigotes using a cut-off dilution of 1:80. Positive sera were titrated till 131 
they gave negative results.  132 
ELISA. The assay was performed by using water soluble proteins of promastigote forms of L. 133 
infantum (zymodeme MON1) as antigens and goat anti-dog IgG antibodies (gamma chain 134 
specific) conjugated to alkaline phosphatase (Kirkegaard and Perry Lab, Inc., Gaithersburg, 135 
MD) as detection antibodies. Samples were considered positive if the absorbance at 405nm 136 
(A405) was above the arithmetic mean plus 3 SD of the A405 values of 48 Leishmania control 137 
dogs originating from a L. infantum, E. canis and Babesia canis free area of Southern 138 
Switzerland (21). Results were expressed in a system of arbitrary antibody units (AU) where 139 
0 AU correspond to the threshold value and 100 AU to the positive standard serum. 140 
DS. A commercially available DS test (Leishmania RapydTest®; DiaSys Europe Ltd., 141 
Wokingam, UK), based on the rk39 antigen and validated for dogs (28) was performed 142 
according to the manufacturer’s instructions (Product Code: 1603; Lot CF 1079 and 143 
GK1062).  144 
 145 
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 7 
E. canis specific antibodies were detected by IFAT by using slides containing fixed E. canis 146 
in DH82 cells (Canine Ehrlichiosis FA Substrate Slide, VMRD, Pullmann, Washington, USA, 147 
Lot P060228-002032908). The parasitized cells were exposed to sera diluted (1:50) in 148 
phosphate buffered saline (pH 7.2) in a moist chamber and, after washing, to fluoresceinated 149 
rabbit anti-dog IgG (Rabbit anti-dog IgG; Sigma - Aldrich Chemie, Germany, Lot 125K4752) 150 
diluted 1:60; both incubations were done at 37°C for 30 min. Samples scored positive when 151 
they produced cytoplasmic inclusion bodies fluorescence at a dilution of 1:50 or higher. All 152 
positive sera were further titrated until the reaction became negative.  153 
2.2.2. Parasitological diagnosis of CanL  154 
Tissue from the popliteal lymph nodes was sampled using a non-aspiration technique (20). 155 
Lymph node smears were stained using Diff Quick Stain (Medical Team Srl, Italy, Lot 156 
100510) and microscopically examined for the presence of amastigote stages (1.5 - 2.0 x 2.5 - 157 
5 µm) of Leishmania parasites.  158 
One skin sample weighing about 30 mg per animal and collection time was taken from the 159 
right shoulder region using a disposable ophthalmology scalpel after clipping the hair over an 160 
area of about 0.5 x 0.5 cm. Samples were stored at –20°C in Eppendorf tubes containing 1 ml 161 
of PBS.  162 
After disruption in liquid nitrogen and pestling (i.e. two thaw- freezing cycles), genomic DNA 163 
was extracted from about 30 mg of skin samples using a commercial kit (Genomic DNA 164 
Purification Kit, Gentra Systems, Minnesota, USA). A L. infantum kinetoplastid minicircle 165 
DNA fragment was amplified using the MC1/MC2 primer pair (6). Genomic DNA solution (4 166 
µl) was added to the PCR reaction mix (46 µl) containing 2.5 mM MgCl2, 10 mM Tris-HCl, 167 
pH 8.3 and 50 mM KCl, 250 µM of each dNTP, 50 pmol of each primer and 1.25 U of Ampli 168 
Taq Gold (Applied Biosystems, Milan, Italy). Optimal conditions for PCR amplification were 169 
standardised as follows: initial denaturation at 94°C for 12 min, 30 cycles consisting of 170 
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 8 
denaturation at 94°C for 30 s, annealing at 60°C for 20 s, extension at 72°C for 30 s, and a 171 
final extension at 72°C for 5 min. A positive control containing genomic L. infantum DNA 172 
and a negative control without DNA were included in all the assays. Amplification products 173 
(~447 bp) were visualised on 2% w/v agarose gels (Ambion, Milan, Italy) upon staining with 174 
ethidium bromide.  175 
 176 
2.3 Statistical analysis  177 
2.3.1 Sample size  178 
The minimum sample size (n=128, i.e. 64 for each kennel) to estimate incidence was 179 
calculated, using the software WinEpiscope 2.0 (39), following these assumptions: dog’s 180 
population for each kennel (n =800), expected incidence 11% (29), maximum error accepted 181 
5% and confidence level (95%). Since a certain number of dogs must be expected to be lost to 182 
follow-up during a long study period, especially in the kennel situation, more than 100 instead 183 
of 64 dogs were enrolled in each group. 184 
2.3.2 Incidence calculation and test performance  185 
Crude incidence was calculated at each sampling date and for each test as the proportion of 186 
positive dogs in comparison to susceptible population. For each calculation dogs previously 187 
positive at the same test were excluded and did not contribute any longer to the incidence 188 
calculation, although they were tested each time. Yearly incidence and apparent recovery 189 
rates (% of dogs positive and resulted negative one year later at the same test) were calculated 190 
at March 2006/2007 and March 2007, respectively, regardless the results of November 2005.  191 
Concordance among serological tests performed in the initial screening (March 2005) on 192 
asymptomatic dogs was evaluated by k statistics (39). Kappa values were ranked as low 193 
(0.2<k<0.4), moderate (0.4<k<0.6), good (0.6<k<0.8), or excellent (k>0.8) as suggested by 194 
Everitt (8). At the follow up examinations (November 2005, March 2006 and March 2007), 195 
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 9 
relative sensitivity (SErel) and relative specificity (SPrel) of the serological tests were assessed 196 
on the basis of the PCR results obtained at the same sampling time. Se and Sp were calculated 197 
according to Greiner and Gardner (11).  198 
Association between PCR results and ELISA AU was screened by one-way analysis of 199 
variance (ANOVA) after converting the AU in log (data+1) to normalize the AU distribution; 200 
association between PCR results and IFAT titer was screened by chi-square test after 201 
categorization of the titer. 202 
Statistical calculations were performed with the statistical package SPSS, version 13.0 for 203 
Windows, and WinEpiscope 2.0 (available at: http://www.clive.ed.ac.uk/winepiscope/). 204 
 205 
3. RESULTS 206 
3.1 Initial screening 207 
The results of the serological tests carried out at the initial screening of 845 dogs are 208 
summarized in Table 1. Overall seroprevalence rates for anti-L. infantum antibodies were 209 
17.3% (positive reaction in one or more tests) and for anti-E. canis antibodies 15% (data not 210 
shown). The prevalence of anti -E. canis antibodies was similar regardless of the serological 211 
status for Leishmania antibodies when assessed by IFAT or DS (ranging from 14.1% to 212 
17.7%), but was significantly higher (χ2 test; p<0.01) in ELISA -positive (26.6%) than in 213 
ELISA -negative dogs (12.4%; Table 1).  214 
Parasites were detected microscopically in stained lymph node smears of 3 (i.e. 0.7%) out of 215 
453 dogs. The above three dogs were positive at serological tests. Concordance between 216 
IFAT and DS was almost perfect (kappa =0.965, rating “excellent”), with only five discordant 217 
cases, whereas concordance with ELISA was lower (54 discordant cases, kappa =0.71, rating 218 
“good”). Test agreement between ELISA and DS was also rated “good” (63 discordant cases, 219 
kappa = 0.678, Table2).  220 
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 10 
3.2 Follow up 221 
The 204 dogs negative for Leishmania in all diagnostic tests, thus enrolled into the 222 
longitudinal study, represented a population homogenous for sex, age, weight and hair length 223 
(χ2 test, p>0.05) and they included 28 dogs (i.e. 13.7%) positive for E. canis antibodies. 224 
Complete two years data sets (all tests, all sampling dates) were available for 173 dogs. 225 
The incidences of CanL and CME calculated for each sampling date and diagnostic technique 226 
are summarized in Table 3. Test specific annual incidence rates of Leishmania infections, 227 
calculated for the periods of March 2005 to March 2006 and March 2006 to March 2007 were 228 
5.7% and 11.4% for PCR, 5% and 5.9% for ELISA, 2.6% and 6.4% for IFAT and 2.1% and 229 
0% for DS (Table 3).  230 
SErel and SPrel of the serological tests determined on the basis of the skin PCR results showed 231 
considerable variations with respect to the diagnostic technique and the sampling date (Table 232 
4). In general, test SErel were low (less than 50%) but test SPrel were high ranging from 92 to 233 
100%. SPrel did not change with time, while SErel showed significant variations among tests 234 
and sampling time. In particular the maximum SErel for all tests was recorded in March 2006 235 
and the lowest after one year in March 2007. The SErel of the ELISA was significantly higher 236 
than that of IFAT and DS for the November 2005 and March 2006 sampling dates. Out of five 237 
dogs classified doubtful at DS test (data not shown), three were negative at all the other 238 
Leishmania and Ehrlichia diagnostic tests at each follow-up while the remaining two were 239 
clearly positive for anti-E. canis antibodies (antibody titres ranging from 1:200 to 1:1.600).  240 
Throughout the two years of observation, 55 animals (i.e. 26.9%) were tested positive for L. 241 
infantum in at least one of the diagnostic tests (Table 5). In particular, 28 animals were 242 
positive only at one of the parasitological tests (i.e. PCR and/or microscopy, group A) while 243 
18 were only serologically positive at one or more tests (group B). Only 9 dogs were both 244 
ACC
EPT
ED
 at UNIVERSITATSSPITAL on M
arch 18, 2009 
cvi.asm
.org
D
ow
nloaded from
 
 11 
parasitologically and serologically positive (group C). Out of the 18 serologically positive 245 
animals of group B, 9 were positive at the ELISA only.  246 
After the first sandfly season in November 2005, 25 animals were positive at one or more 247 
tests. Among them, 11 dogs were positive at the PCR only, 11 at one of the serological tests 248 
only (ELISA =9; IFAT =2) and 3 were both, parasitologically and serologically positive. The 249 
remaining 30 animals become positive at least one of the parasitological and/or serological 250 
tests at the following sampling times (i.e. on March 2006 or March 2007) (Table 5).  251 
At the final follow-up date (March 2007), only seven animals (4%) out of the remaining 173 252 
showed symptoms of leishmaniasis (i.e. dermatitis, lymphadenopathy, conjunctivitis, skin 253 
ulcers) (Table 5). Two among them belonged to group A and B, respectively, while the 254 
remaining five animals belonged to group C. The 32 dogs ELISA positive throughout the 255 
observation period showed AU levels ranging from 0.08 to 96.79. Only 5 of these dogs were 256 
PCR positive and were significantly associated with higher ELISA titers (p<0.05). In 257 
particular 4 PCR positives showed above 7.5 AU in ELISA,  while only 1 was 0.73. Out of 22 258 
IFAT positive dogs, 7 were also PCR positive and showed no statistical association with 259 
titers. In particular 4 PCR positive were IFAT positive at 1:80, 1 at 1:160 and 2 at 1:320.   260 
 261 
4. DISCUSSION  262 
The results of the present work clearly imply that diagnosis of early CanL and identification 263 
of asymptomatic carrier animals in an endemic area might be a complex task. Indeed, at the 264 
initial screening while the seropositivity to L. infantum was similar at IFAT and DS (i.e. about 265 
9.5%) it was higher when inferred by ELISA (i.e. ~17%). Both, IFAT and DS are less 266 
sensitive than ELISA for the detection of specific antibodies in asymptomatic dogs without 267 
other infections and kept outside of an endemic area (21). In the present study focusing on 268 
early infections in animals living in an endemic area, ELISA proved to be the most sensitive 269 
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serological test on two occasions (November 2005 and March 2006) whereas no significant 270 
differences between the serological tests were noted in March 2007.  271 
The significantly higher percentage of positive ELISA results in dogs also positive for E. 272 
canis antibodies (Table 1), indicates some kind of interaction between the two tests. One 273 
possible explanation is a cross-reaction of ELISA test, resulting in false Leishmania positives, 274 
or it is also possible that Leishmania specific antibodies detectable only by the ELISA might 275 
be responsible for false positive reactions in the Ehrlichia IFAT.  276 
Nonetheless, E. canis infection might induce immunosupression and therefore potentially 277 
increase the susceptibility of infection to L. infantum (14). It is broadly accepted, that 278 
threshold levels of any serological test should be adapted to meet the local conditions. This is 279 
reflected by the finding that in our study 44.7% of sera positive only at ELISA at the initial 280 
sampling were only marginally above the cut-off level. The concordance between IFAT and 281 
DS (K=0.965) tests was high, with only few discordant cases (Table 2). However, IFAT is 282 
also a quantitative test which could provide useful information about the immune reactivity of 283 
L. infantum infected individuals. rK39 DS represents an alternative to currently available 284 
diagnostic tests, especially when used in mass screening surveys in which antibody titers are 285 
not required, and it is ideal for use under field conditions. Again, DS test was validated vs. 286 
IFAT using sera from dogs positive or negative at lymph node smear parasitological 287 
examination thus in animals with a visceral generalized form of infection (28). Accordingly, 288 
by comparing ELISA, IFAT and rK39 DS the latter test showed to be mainly helpful for 289 
confirming clinically suspected cases while it was not very sensitive in detecting 290 
asymptomatic infections (21). Consequently, in asymptomatic animals from endemic areas a 291 
negative serological DS test may result from sub-clinically infected animals as well a positive 292 
test from dogs co-infected by E. canis (28). Thus, all serological tests should be evaluated 293 
carefully according to the epidemiological context of the area and the aim of the investigation. 294 
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 13 
In addition, in asymptomatic animals a low humoral reactivity may lead to low antibody 295 
concentration and, ultimately, to borderline titers which may result in false negative or 296 
positive due to cross -reactivity (15).  297 
Compared to spleen and bone marrow, popliteal lymph nodes have been shown to be the most 298 
suitable tissue for direct parasitological detection in L. infantum infected symptomatic animals 299 
(25). Conversely, in asymptomatic animals at initial screening cytology showed a very low 300 
percentage of positivity (i.e. 0.7%) and low Se when compared to serological techniques as 301 
already demonstrated in animals from endemic areas (34). Thus cytology on lymph node is 302 
not useful to diagnose Leishmania infection in asymptomatic animals since protozoa may 303 
remain at dermal site or may be present with a low parasitic load (15) as a consequence of an 304 
effective immune response (31). Similarly, out of the 55 animals newly infected at one or 305 
more follow-ups only 9 (i.e. 16.3%) were positive at the cytological examination which 306 
indicate that cytology should be not the first choice parasitological test in diagnosing L. 307 
infantum asymptomatic animals. Again, the difficulties in sample collection from not enlarged 308 
lymph nodes impair the use of cytology in asymptomatic animals. Interestingly, five out the 9 309 
animals positive at cytological examination showed clinical symptoms while other 3 became 310 
positive only at final follow-up (Table 5) thus being not possible to evaluate the appearance of 311 
clinical signs. Only one dog positive at cytology and PCR on March 2006 became negative at 312 
all tests in the last follow-up.  313 
In the last decades, different protocols of PCR were shown to be sensitive and specific to 314 
diagnose CanL in a variety of animal tissues (i.e. bone marrow, lymph nodes, skin and blood- 315 
[9]). A number of studies investigated different gene markers and protocols for the diagnosis 316 
of CanL but results are in many cases discordant. PCR on skin samples (at any collection 317 
time) was positive in 34 (i.e. 61.8%) out of 55 infected animals. Although PCR on skin 318 
samples cannot be considered as a “gold standard” for detecting L. infantum, especially in 319 
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endemic areas (36) it most likely is the more sensitive method for diagnosing animal exposure 320 
to sandflies bites and/or infection.  321 
Accordingly, the results of the annual incidence of Leishmania infection, calculated in March 322 
2006 and March 2007 were variable depending by the test employed with the highest values 323 
registered at the PCR (i.e. 5.7% and 11.4%) followed by the ELISA, IFAT and DS. However, 324 
by calculating the SErel and SPrel of the serological tests on the basis of the results of the skin 325 
PCR, the SErel was always very low while the SPrel was good (from 92 to 100%, Table 4). As 326 
a consequence, serological tests are not optimal to detect exposed or newly infected animals. 327 
Indeed, since dogs infected by L. infantum (especially if asymptomatic) might not seroconvert 328 
immediately after infection or they may develop an immune responsiveness oriented toward a 329 
self healing cellular immune reaction, serological test may lead to false-negative results.  330 
From a parasitological standpoint, molecular detection of L. infantum on skin samples may 331 
indicate prior exposure to infected phlebotomine sand fly bites but also an active infection in 332 
resistant (i.e. immunocompetent) dogs, or both (38). 333 
The above issue remains one of the crucial and debated aspect in diagnosing CanL in 334 
asymptomatic dogs. Indeed, a dog which has been bitten by one or more L. infantum infected 335 
sandflies should be considered an individual which has been “exposed” and so far which 336 
needs to be monitored in the follow-up. Similarly, in a previous study 37% of seronegative 337 
asymptomatic dogs from an endemic area were positive at the PCR on skin as a likely 338 
consequence of an effective cellular immunity (37). L. infantum promastigotes start 339 
developing into macrophage cells at the site of inoculation in its amastigote forms and the 340 
infection may spread resulting into a “systemic form” (26). At this stage an antibody immune 341 
responsiveness should occur according to the individual immune reactivity (3). The above 342 
infection pattern could explain the reason why at the first follow-up on November 2005, 10 343 
animals were positive only at the Leishmania PCR test. Although an animal positive at PCR 344 
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on skin samples has to be considered exposed, neither serological nor molecular tests may 345 
predict if it will remain long-lasting asymptomatic, it will clear the infection or exhibit 346 
progressive leishmaniasis. Accordingly, three animals which resulted positive for Leishmania 347 
only at the first screening, at the second converted to negative more likely as an affect of a 348 
clearing of infection. A similar picture was previously recorded in asymptomatic animals 349 
positive at nested PCR on bone marrow that converted into negative at the follow up (27).  350 
Out of 55 animals positive at least at one test performed for L. infantum (see Table 5) only 351 
seven (12.7%) showed clinical signs related to CanL infection on March 2007 while the 352 
remaining 48 (87.3%) were all asymptomatic. These data nicely fit with percentage of 353 
asymptomatic dogs recorded in Brazil (i.e. 85.3% [7]). Although the clinical appearance of 354 
symptoms cannot be ruled out in the follow-up of L. infantum infected animals, the results of 355 
the present survey confirm the high prevalence of asymptomatic dogs in endemic area and 356 
pinpoint their potential role in spreading the disease to receptive hosts. Infected asymptomatic 357 
animals contribute in maintaining the endemicity of the disease by transmitting Leishmania 358 
spp. to new hosts (dogs or humans) via sandfly bites (22). Under the above circumstances, 359 
monitoring asymptomatic infected animals may be of relevance not only for the 360 
epidemiological evaluation of CanL in endemic areas but also to control the infection in 361 
human and dog populations by preventing sandfly bites both on infected and uninfected hosts.  362 
The data presented clearly shows that there is no gold standard to detect Leishmania 363 
infections in asymptomatic dogs and highlights the difficulty to propose a clear diagnostic 364 
scheme to assess the infection status of asymptomatic dogs. Therefore, more than one test 365 
should be used for the diagnosis of CanL in endemic areas. 366 
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TABLE 1. Detection of anti -Leishmania infantum antibodies by different tests (i.e. IFAT, 499 
ELISA, dipstick -DS) at the study starting point as well as anti -Ehrlichia canis antibodies in 500 
dogs with (L-pos) or without (L-neg) detectable anti -L. infantum antibodies 501 
* p<0.001 502 
Test Anti -Leishmania infantum antibodies Anti -Ehrlichia canis antibodies 
  L-pos dogs L-neg dogs 
IFAT 79/831 (9.5%) 14/79 (17.7%) 106/752 (14.1%) 
ELISA 143/837 (17.1%) 38/143 (26.6%)* 86/694 (12.4%)* 
DS 83/845 (9.8%) 14/83 (16.9%) 112/762 (14.7%) 
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TABLE 2. Measure of agreement (kappa values) among results (expressed as negative –neg- 503 
and positive -pos) of IFAT, ELISA, dipstick (DS) Leishmania tests calculated on 845 dogs at 504 
the study starting point. 505 
 506 
Tests and results Kappa value (rank) and significance 
 DS neg DS pos  
IFAT neg 750 2 k=0.965 (“excellent”) 
IFAT pos 3 76 p<0.001 
 ELISA neg ELISA pos  
IFAT neg 692 54 k=0.710 (“good”) 
IFAT pos 0 79 p<0.001 
 DS neg DS pos  
ELISA neg 694 0 k=0.678 (“good”) 
ELISA pos 63 80 p<0.001 
 507 
 508 
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 509 
TABLE 3. Prevalence at starting point and incidence rates (I) of Leishmania infantum and 510 
Ehrlichia canis infection calculated for each diagnostic technique. Dogs previously positive at 511 
the same test were excluded from calculation 512 
 513 
 Leishmania Ehrlichia 
 ELISA IFAT DS* PCR IFAT 
 I (pos/N) I (pos/N) I (pos/N) I (pos/N) I (pos/N) 
Prevalence at starting point 
Mar. 05 0% (0/204) 0% (0/204) 0% (0/204) 0% (0/204) 13.7% (28/204) 
Intermediate incidence determinations 
Mar. 05 –Nov. 05 5.1% (9/178) 2.0% (4/196) 
0% (0/196) 
13 doubtful 7.2% (14/195) 20/168 (11.9%) 
Nov. 05- Mar.06 2.0% (3/149) 1.1% (2/187) 
2.2% (4/179) 
4 doubtful 0.6% (1/178)  5/146 (3.4%) 
Yearly incidence rates 
Mar. 05-06 5.0% (8/159) 2.6% (5/192) 2.1 (4/192) 5.7% (11/193) 13.8 (25/176) 
Mar. 06-07 5.9% (9/153) 6.4% (11/173) 0% (0/168) 11.4% (19/166) 9.3% (13/139) 
Yearly recovery rates (neg’07/pos’06) 
Mar. 06-07 33.3% (2/6) 25% (1/3) all 60% (6/10) 25.6% (10/39) 
* doubtful results were considered negative 514 
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TABLE 4. Relatives sensitivity (SErel) and relative specificity (SPrel) of IFAT, ELISA, 515 
dipstick (DS) Leishmania serological tests compared to the PCR on skin in asymptomatic 516 
dogs. 517 
 November 2005 March 2006 March 2007 
 
SErel SPrel SErel Sprel SErel SPrel 
ELISA 33%aAB 95% 50% bcAC 95.5% 9% BC 93% 
IFI 14% aD 99% 27% bDE 99% 13% E 92% 
DS - - 18% CF 99% 4.5% F 100% 
Equal letters correspond to significant difference for p<0.01 518 
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TABLE 5. Diagnostic follow up of the 55 dogs resulted positive for Leishmania infantum 519 
infection at one or more tests 520 
November 05 March 06 March 07 No. of dogs IFAT DS ELISA PCR IFAT DS ELISA Mic PCR IFAT DS ELISA Mic PCR 
Group A (28), parasitologically positive animals 
15              + 
4*    +     +      
3    +     +     + 
3    +           
2             + + 
1        + +      
Group B (18), serologically positive animals 
5            +   
2   +            
2   +    +        
3   +    +   +  +   
1          +     
1   +       +  +   
1       +        
1*   +       +     
1          +  +   
1 +    + +    +  +   
Group C (9), parasitologically and serologically positive animals 
2*          +   +  
1*    + +   + +   +   
1 +   +           
1            +  + 
1 +   + + +   + d d d d d 
1*   + + + + +  + + + + + + 
1* +    + +    +  +  + 
1*        +  +   +  
 521 
*Single animals which showed symptoms of leishmaniasis (i.e. dermatitis, 522 
lymphadenopathy, –conjunctivitis, skin ulcers) and/or hypergammaglobulinemia in each 523 
line; d, dead animals. 524 
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